क्यूआर कोड

Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting

Abstract Background In a recent post hoc analysis of multinational clinical trial data, dupilumab treatment for patients with moderate or severe atopic dermatitis (AD) reduced all‐cause and AD‐related hospitalisations. Objectives We studied the impact of dupilumab on health care resource utilisation...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Ken Igawa, Hiroyuki Fujita, Yuki Tajima, Robert Lubwama, Moataz Daoud, Zhixiao Wang, Kazuhiko Arima
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Wiley 2023-09-01
श्रृंखला:JEADV Clinical Practice
विषय:
ऑनलाइन पहुंच:https://doi.org/10.1002/jvc2.151
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!